
  Mrv0541 04191212102D          

 10 10  0  0  0  0            999 V2000
   -0.1480    0.2044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1480   -0.6206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8625    0.6169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5665    0.6169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8625   -1.0331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5770    0.2044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2809    0.2044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5770   -0.6206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2809   -0.6206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9954    0.6169    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  3  6  1  0  0  0  0
  4  7  1  0  0  0  0
  5  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
  6  8  2  0  0  0  0
M  END
> <DATABASE_ID>
DB00182

> <DATABASE_NAME>
drugbank

> <SMILES>
CC(N)CC1=CC=CC=C1

> <INCHI_IDENTIFIER>
InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3

> <INCHI_KEY>
KWTSXDURSIMDCE-UHFFFAOYSA-N

> <FORMULA>
C9H13N

> <MOLECULAR_WEIGHT>
135.2062

> <EXACT_MASS>
135.104799421

> <JCHEM_ACCEPTOR_COUNT>
1

> <JCHEM_AVERAGE_POLARIZABILITY>
16.174738885675872

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
1

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
0

> <JCHEM_IUPAC>
1-phenylpropan-2-amine

> <ALOGPS_LOGP>
1.85

> <JCHEM_LOGP>
1.8042504816666665

> <ALOGPS_LOGS>
-1.89

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
1

> <JCHEM_PHYSIOLOGICAL_CHARGE>
1

> <JCHEM_PKA_STRONGEST_BASIC>
10.01443581771614

> <JCHEM_POLAR_SURFACE_AREA>
26.02

> <JCHEM_REFRACTIVITY>
43.7052

> <JCHEM_ROTATABLE_BOND_COUNT>
2

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
1.74e+00 g/l

> <JCHEM_TRADITIONAL_IUPAC>
adderall

> <JCHEM_VEBER_RULE>
1

> <DRUGBANK_ID>
DB00182

> <SECONDARY_ACCESSION_NUMBERS>
APRD00480

> <DRUG_GROUPS>
approved; illicit; investigational

> <GENERIC_NAME>
Amphetamine

> <SYNONYMS>
(+-)-alpha-Methylphenylethylamine; 1-phenyl-2-aminopropane; alpha-Methylbenzeneethaneamine; Amfetamina; Amfetamine; Amfetaminum; Amphetamine; beta-Aminopropylbenzene; beta-Phenylisopropylamin; Desoxynorephedrine; rac-(2R)-1-phenylpropan-2-amine; rac-amphetamine; α-methylbenzeneethaneamine; α-methylphenethylamine; β-aminopropylbenzene; β-phenylisopropylamine

> <PRODUCTS>
Act Amphetamine XR; Adderall; Adderall XR; Adzenys ER; Adzenys XR-ODT; Amphetamine Extended-Release Oral Suspension; Amphetamine Sulfate; Apo-amphetamine XR; Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate; Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate; Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate; Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate; Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Suflate; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate; Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate; Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate; Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER; Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate; Dyanavel XR; Evekeo; Evekeo ODT; Mixed Salts of a Single Entity Amphetamine Product XR; Mydayis; PMS-amphetamines XR; Sandoz Amphetamine XR

> <SALTS>
Amphetamine adipate; Amphetamine aspartate; Amphetamine aspartate monohydrate; Amphetamine sulfate

$$$$

  Mrv1909 07021918052D          

  9  8  0  0  0  0            999 V2000
    0.3610   -0.4091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3610   -1.2400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3610    0.4174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3528    0.8309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0750    0.4174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7889    0.8309    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.3610    1.2400    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0750    0.8309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7889    0.4174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  3  0  0  0  0
  3  1  1  0  0  0  0
  4  3  1  0  0  0  0
  5  4  2  0  0  0  0
  6  5  1  0  0  0  0
  7  3  1  0  0  0  0
  8  3  1  0  0  0  0
  9  8  1  0  0  0  0
M  END
> <DATABASE_ID>
DB00189

> <DATABASE_NAME>
drugbank

> <SMILES>
CCC(O)(\C=C\Cl)C#C

> <INCHI_IDENTIFIER>
InChI=1S/C7H9ClO/c1-3-7(9,4-2)5-6-8/h1,5-6,9H,4H2,2H3/b6-5+

> <INCHI_KEY>
ZEHYJZXQEQOSON-AATRIKPKSA-N

> <FORMULA>
C7H9ClO

> <MOLECULAR_WEIGHT>
144.6

> <EXACT_MASS>
144.0341926

> <JCHEM_ACCEPTOR_COUNT>
1

> <JCHEM_ATOM_COUNT>
18

> <JCHEM_AVERAGE_POLARIZABILITY>
14.766102360555642

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
1

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
0

> <JCHEM_IUPAC>
(1E)-1-chloro-3-ethylpent-1-en-4-yn-3-ol

> <ALOGPS_LOGP>
1.45

> <JCHEM_LOGP>
1.620819461

> <ALOGPS_LOGS>
-3.00

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
0

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_PKA_STRONGEST_ACIDIC>
12.877910831568652

> <JCHEM_PKA_STRONGEST_BASIC>
-3.727001802271872

> <JCHEM_POLAR_SURFACE_AREA>
20.23

> <JCHEM_REFRACTIVITY>
38.6382

> <JCHEM_ROTATABLE_BOND_COUNT>
2

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
1.43e-01 g/l

> <JCHEM_TRADITIONAL_IUPAC>
ethchlorvynol

> <JCHEM_VEBER_RULE>
1

> <DRUGBANK_ID>
DB00189

> <SECONDARY_ACCESSION_NUMBERS>
APRD00958

> <DRUG_GROUPS>
approved; illicit; withdrawn

> <GENERIC_NAME>
Ethchlorvynol

> <SYNONYMS>
1-chloro-3-ethyl-1-penten-4-yn-3-ol; 1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol; 3-(beta-chlorovinyl)-1-pentyn-3-ol; 3-(β-chlorovinyl)-1-pentyn-3-ol; etclorvinol; Ethchlorvynol; ethyl β-chlorovinyl ethynyl carbinol; β-chlorovinyl ethyl ethynyl carbinol

> <PRODUCTS>
Placidyl Cap 200mg; Placidyl Cap 500mg; Placidyl Cap 750mg

> <INTERNATIONAL_BRANDS>
Arvynol; Nostel; Placidyl; Roeridorm; Serenesil

$$$$
191
  Mrv0541 02231214302D          

 11 11  0  0  0  0            999 V2000
    3.7935    1.3943    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0791    0.9818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3645    0.5693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6665    1.6962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4916    0.2673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3645   -0.2558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0791   -0.6683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500   -0.6683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0791   -1.4933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500   -1.4933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3645   -1.9058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  8 10  2  0  0  0  0
  9 11  2  0  0  0  0
 10 11  1  0  0  0  0
M  END
> <DATABASE_ID>
DB00191

> <DATABASE_NAME>
drugbank

> <SMILES>
CC(C)(N)CC1=CC=CC=C1

> <INCHI_IDENTIFIER>
InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3

> <INCHI_KEY>
DHHVAGZRUROJKS-UHFFFAOYSA-N

> <FORMULA>
C10H15N

> <MOLECULAR_WEIGHT>
149.2328

> <EXACT_MASS>
149.120449485

> <JCHEM_ACCEPTOR_COUNT>
1

> <JCHEM_AVERAGE_POLARIZABILITY>
17.87496804528466

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
1

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
0

> <JCHEM_IUPAC>
2-methyl-1-phenylpropan-2-amine

> <ALOGPS_LOGP>
2.32

> <JCHEM_LOGP>
2.0848271499999997

> <ALOGPS_LOGS>
-2.29

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
1

> <JCHEM_PHYSIOLOGICAL_CHARGE>
1

> <JCHEM_PKA_STRONGEST_BASIC>
10.248513745149388

> <JCHEM_POLAR_SURFACE_AREA>
26.02

> <JCHEM_REFRACTIVITY>
48.34340000000002

> <JCHEM_ROTATABLE_BOND_COUNT>
2

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
7.57e-01 g/l

> <JCHEM_TRADITIONAL_IUPAC>
phentermine

> <JCHEM_VEBER_RULE>
1

> <DRUGBANK_ID>
DB00191

> <SECONDARY_ACCESSION_NUMBERS>
APRD00093

> <DRUG_GROUPS>
approved; illicit

> <GENERIC_NAME>
Phentermine

> <SYNONYMS>
alpha,alpha-Dimethylphenethylamine; Fentermina; Phentermine; Phentermine resin; Phenterminum

> <PRODUCTS>
Adipex-P; Fastin Cap 30mg; Ionamin; Lomaira; Phentermine; Phentermine HCl; Phentermine HCl C-IV; Phentermine Hydrochloride; Phentermine Resin ER; Phentermine hydrochloride; Phetermine Hydrochloride; Qsymia; Suprenza

> <INTERNATIONAL_BRANDS>
Dapex; Duromine; Fastin; Obenix; Obestin-30; Oby-trim; Phentercot; Phentride; Umi-Pex

> <SALTS>
Phentermine hydrochloride

$$$$
237
  Mrv0541 02231214322D          

 15 15  0  0  1  0            999 V2000
    4.5080    0.1658    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500    0.1658    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0791   -2.3092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7935   -1.0717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3645   -1.0717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0791    0.1658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4916    0.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6665    0.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0791    1.5948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7935   -0.2467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3645   -0.2467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3166    0.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8415    0.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4916    2.3092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0791   -1.4842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  2  0  0  0  0
  2 11  2  0  0  0  0
  3 15  2  0  0  0  0
  4 10  1  0  0  0  0
  4 15  1  0  0  0  0
  5 11  1  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6 10  1  0  0  0  0
  6 11  1  0  0  0  0
  7  9  1  0  0  0  0
  7 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 14  1  0  0  0  0
M  END
> <DATABASE_ID>
DB00237

> <DATABASE_NAME>
drugbank

> <SMILES>
CCC(C)C1(CC)C(=O)NC(=O)NC1=O

> <INCHI_IDENTIFIER>
InChI=1S/C10H16N2O3/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15)

> <INCHI_KEY>
ZRIHAIZYIMGOAB-UHFFFAOYSA-N

> <FORMULA>
C10H16N2O3

> <MOLECULAR_WEIGHT>
212.2456

> <EXACT_MASS>
212.116092388

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_AVERAGE_POLARIZABILITY>
21.410874790436942

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
1

> <JCHEM_IUPAC>
5-(butan-2-yl)-5-ethyl-1,3-diazinane-2,4,6-trione

> <ALOGPS_LOGP>
1.70

> <JCHEM_LOGP>
1.4486825816666666

> <ALOGPS_LOGS>
-2.18

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
1

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_PKA>
12.151890058493215

> <JCHEM_PKA_STRONGEST_ACIDIC>
8.482024390046842

> <JCHEM_POLAR_SURFACE_AREA>
75.27

> <JCHEM_REFRACTIVITY>
53.40189999999999

> <JCHEM_ROTATABLE_BOND_COUNT>
3

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
1.39e+00 g/l

> <JCHEM_TRADITIONAL_IUPAC>
butabarbital

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB00237

> <SECONDARY_ACCESSION_NUMBERS>
APRD00752

> <DRUG_GROUPS>
approved; illicit

> <GENERIC_NAME>
Butabarbital

> <SYNONYMS>
5-ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-ethyl-5-(1-methylpropyl)barbituric acid; 5-sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-sec-butyl-5-ethylbarbituric acid; 5-sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione; Butabarbital; Secbutabarbital; Secbutabarbitale; Secbutabarbitalum

> <PRODUCTS>
Butisol Sodium; Butisol Sodium Tab 100mg; Butisol Sodium Tab 15mg; Butisol Sodium Tab 30mg; Phenazopyridine Hydrochloride, Hyoscyamine Hydrobromide, and Butabarbital; Phenazopyridine Plus; Pyrelle H.B.

> <INTERNATIONAL_BRANDS>
Butalan; Butisol; Sarisol No. 2

> <SALTS>
Butabarbital sodium

$$$$
241
  Mrv0541 02231214322D          

 16 16  0  0  0  0            999 V2000
    4.7291    0.1658    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8711    0.1658    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3001   -2.3092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0145   -1.0717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5856   -1.0717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3001    0.1658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7126    0.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3001    1.5948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8876    0.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0145   -0.2467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5856   -0.2467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4751    1.5948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7126    2.3092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0625    0.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3001   -1.4842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500    1.5948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  2  0  0  0  0
  2 11  2  0  0  0  0
  3 15  2  0  0  0  0
  4 10  1  0  0  0  0
  4 15  1  0  0  0  0
  5 11  1  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  6  9  1  0  0  0  0
  6 10  1  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  8 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 14  1  0  0  0  0
 14 16  2  0  0  0  0
M  END
> <DATABASE_ID>
DB00241

> <DATABASE_NAME>
drugbank

> <SMILES>
CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O

> <INCHI_IDENTIFIER>
InChI=1S/C11H16N2O3/c1-4-5-11(6-7(2)3)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16)

> <INCHI_KEY>
UZVHFVZFNXBMQJ-UHFFFAOYSA-N

> <FORMULA>
C11H16N2O3

> <MOLECULAR_WEIGHT>
224.2563

> <EXACT_MASS>
224.116092388

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_AVERAGE_POLARIZABILITY>
22.424209910653055

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
1

> <JCHEM_IUPAC>
5-(2-methylpropyl)-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione

> <ALOGPS_LOGP>
1.47

> <JCHEM_LOGP>
1.5892632603333325

> <ALOGPS_LOGS>
-2.00

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
1

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_PKA>
12.151206288215347

> <JCHEM_PKA_STRONGEST_ACIDIC>
8.481397724138178

> <JCHEM_POLAR_SURFACE_AREA>
75.27

> <JCHEM_REFRACTIVITY>
58.047

> <JCHEM_ROTATABLE_BOND_COUNT>
4

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
2.23e+00 g/l

> <JCHEM_TRADITIONAL_IUPAC>
butalbital

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB00241

> <SECONDARY_ACCESSION_NUMBERS>
APRD00266

> <DRUG_GROUPS>
approved; illicit

> <GENERIC_NAME>
Butalbital

> <SYNONYMS>
5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione; 5-allyl-5-(2-methylpropyl)barbituric acid; 5-allyl-5-(2'-methyl-n-propyl) barbituric acid; 5-allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione; 5-allyl-5-isobutylbarbituric acid; 5-isobutyl-5-allylbarbituric acid; Allylbarbital; Allylbarbitone; Allylbarbituric acid; Butalbarbital; Butalbital; Butalbitalum; iso-butylallylbarbituric acid; Itobarbital; Tetrallobarbital

> <PRODUCTS>
Acetaminophen, Butalbital and Caffeine; Alagesic LQ; Allzital; Ascomp with Codeine; Bupap; Butalbital Acetaminophen and Caffeine; Butalbital And Acetaminophen; Butalbital Compound; Butalbital and Acetaminophen; Butalbital and Acetaminophen 50 mg/325 mg; Butalbital, Acetaminophen and Caffeine; Butalbital, Acetaminophen and Caffeine Plus; Butalbital, Acetaminophen and Caffeine with Codeine Phosphate; Butalbital, Acetaminophen, Caffeine; Butalbital, Acetaminophen, Caffeine and Codeine Phosphate; Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate; Butalbital, Acetaminophen, and Caffeine; Butalbital, Acetominophen and Caffeine; Butalbital, Aspirin and Caffeine; Butalbital, Aspirin, Caffeine and Codeine Phosphate; Butalbital, Aspirin, Caffeine, and Codeine Phosphate; Butalbital, Aspirin, and Caffeine; Butalbital, aspirin, and caffeine; Butapap; Capacet; Dolgic Plus; Esgic; Esgic-Plus; Fioricet; Fioricet with Codeine; Fiorinal; Fiorinal Tab; Fiorinal with Codeine; Fiorinal-C 1/2; Fiorinal-C 1/4; Margesic; Marten-Tab; Orbivan; Orbivan CF; PMS-pharnal Capsules; PMS-pharnal Tablets; PMS-pharnal-C 1/4 Capsules; PMS-pharnal-C1/2 Capsules; Phrenilin; Phrenilin Forte; Pronal - C1/2 Capsules; Pronal C1/4 Capsules; Pronal Capsules; Pronal Tablets; Tencon; Teva-tecnal; Teva-tecnal C 1/2; Teva-tecnal C 1/4; Trianal Capsules; Trianal C¼; Trianal C½; Trianal Tablet; Vanatol LQ; Vanatol S; Vtol LQ; Zebutal

> <INTERNATIONAL_BRANDS>
Sandoptal

> <SALTS>
Butalbital sodium

$$$$

  Mrv0541 08081309442D          

 16 16  0  0  1  0            999 V2000
    1.8711    0.1658    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7291    0.1658    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3001   -2.3092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5856   -1.0717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0145   -1.0717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3001    0.1658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7126    0.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8876    0.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3001    1.5948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5856   -0.2467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0145   -0.2467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5376    0.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3001   -1.4842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7126    2.3092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0625    0.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500    1.5948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  2  0  0  0  0
  2 11  2  0  0  0  0
  3 13  2  0  0  0  0
  4 10  1  0  0  0  0
  4 13  1  0  0  0  0
  5 11  1  0  0  0  0
  5 13  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6 10  1  0  0  0  0
  6 11  1  0  0  0  0
  7  9  1  0  0  0  0
  7 12  1  0  0  0  0
  8 15  1  0  0  0  0
  9 14  1  0  0  0  0
 15 16  2  0  0  0  0
M  END
> <DATABASE_ID>
DB00306

> <DATABASE_NAME>
drugbank

> <SMILES>
CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O

> <INCHI_IDENTIFIER>
InChI=1S/C11H16N2O3/c1-4-6-11(7(3)5-2)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16)

> <INCHI_KEY>
BJVVMKUXKQHWJK-UHFFFAOYSA-N

> <FORMULA>
C11H16N2O3

> <MOLECULAR_WEIGHT>
224.2563

> <EXACT_MASS>
224.116092388

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_AVERAGE_POLARIZABILITY>
22.482020735327588

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
1

> <JCHEM_IUPAC>
5-(butan-2-yl)-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione

> <ALOGPS_LOGP>
1.87

> <JCHEM_LOGP>
1.5892632603333325

> <ALOGPS_LOGS>
-1.96

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
1

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_PKA>
12.14833825700984

> <JCHEM_PKA_STRONGEST_ACIDIC>
8.478768535925882

> <JCHEM_POLAR_SURFACE_AREA>
75.27

> <JCHEM_REFRACTIVITY>
58.047

> <JCHEM_ROTATABLE_BOND_COUNT>
4

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
2.46e+00 g/l

> <JCHEM_TRADITIONAL_IUPAC>
talbutal

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB00306

> <SECONDARY_ACCESSION_NUMBERS>
APRD01333

> <DRUG_GROUPS>
approved; illicit

> <GENERIC_NAME>
Talbutal

> <SYNONYMS>
(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione; 5-allyl-5-sec-butylbarbituric acid; sec-Butyl allyl barbituric acid; Talbutal; Talbutale; Talbutalum

> <INTERNATIONAL_BRANDS>
Lotusate

$$$$

  Mrv1902 04141921032D          

 23 27  0  0  0  0            999 V2000
   -0.3917   -0.4145    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.3952    0.4076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3139   -0.8309    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.1115   -0.8203    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.3139    0.0053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1115    0.8170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3174    0.8170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0302   -0.4216    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.3105   -1.6530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9301    0.0546    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1151   -1.6426    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.7397   -0.0087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1115    1.6462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0338    0.4040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3174    1.6462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7466   -0.8380    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4057   -2.0590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8349   -2.0554    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3917    2.0590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8279    2.0590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5442   -0.6192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5442    1.6462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1009   -1.3991    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  1  0  0  0
  2  6  2  0  0  0  0
  2  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4 10  1  6  0  0  0
  4 11  1  0  0  0  0
  6 13  1  0  0  0  0
  7 14  1  0  0  0  0
  7 15  2  0  0  0  0
  8 16  1  1  0  0  0
  9 17  2  0  0  0  0
 11 18  1  6  0  0  0
 13 19  2  0  0  0  0
 13 20  1  0  0  0  0
 16 21  1  0  0  0  0
 20 22  1  0  0  0  0
  6 10  1  0  0  0  0
  8 14  1  0  0  0  0
 11 17  1  0  0  0  0
 12 16  1  0  0  0  0
 15 19  1  0  0  0  0
  3 23  1  1  0  0  0
  5 12  1  0  0  0  0
M  END
> <DATABASE_ID>
DB00318

> <DATABASE_NAME>
drugbank

> <SMILES>
[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC

> <INCHI_IDENTIFIER>
InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1

> <INCHI_KEY>
OROGSEYTTFOCAN-DNJOTXNNSA-N

> <FORMULA>
C18H21NO3

> <MOLECULAR_WEIGHT>
299.3642

> <EXACT_MASS>
299.152143543

> <JCHEM_ACCEPTOR_COUNT>
4

> <JCHEM_ATOM_COUNT>
43

> <JCHEM_AVERAGE_POLARIZABILITY>
31.945923610648677

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
1

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
1

> <JCHEM_IUPAC>
(1S,5R,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraen-14-ol

> <ALOGPS_LOGP>
1.20

> <JCHEM_LOGP>
1.3429512830000006

> <ALOGPS_LOGS>
-2.72

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
5

> <JCHEM_PHYSIOLOGICAL_CHARGE>
1

> <JCHEM_PKA_STRONGEST_ACIDIC>
13.782739294723577

> <JCHEM_PKA_STRONGEST_BASIC>
9.19278496599547

> <JCHEM_POLAR_SURFACE_AREA>
41.93

> <JCHEM_REFRACTIVITY>
84.60470000000001

> <JCHEM_ROTATABLE_BOND_COUNT>
1

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
5.77e-01 g/l

> <JCHEM_TRADITIONAL_IUPAC>
(1S,5R,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraen-14-ol

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB00318

> <SECONDARY_ACCESSION_NUMBERS>
APRD00120; DB09471

> <DRUG_GROUPS>
approved; illicit

> <GENERIC_NAME>
Codeine

> <SYNONYMS>
(−)-Codeine; (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol; 7,8-didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol; Codein; Codeína; Codéine; Codeine anhydrous; Codeine polistirex; Codeinum; L-Codeine; Methylmorphine; morphine 3-methyl ether; Morphine monomethyl ether; morphine-3-methyl ether; O3-Methylmorphine

> <PRODUCTS>
(extra Strength) Acetaminophen, Caffeine & 8mg Codeine Phosphate Caplets; 222 Tablets; 282 Mep Tab; 282 Tab; 282 Tablets; 292 Tab; 292 Tablets; A & C Tablets With Codeine 15mg; A & C Tablets With Codeine 30mg; A.C. & C 8mg Tab; A.C. & C. 8 mg; A.C. & C. 8mg; A.C.& C Tablets; ACETAMINOPHEN AND CODEINe; ACETAMINOPHEN with CODEINE; Ac and C Tab 1/8gr; Ac&c Tablets; Acet 2; Acet 3; Acet Codeine 30; Acet Codeine 60; Acetaminophen 300mg, Caffeine & Codeine; Acetaminophen 325 C & C; Acetaminophen 325 Mg Caffeine and Codeine; Acetaminophen 325 Mg With 15 Mg Caffeine and 8 Mg Codeine Phosphate; Acetaminophen 500 Mg Compound Tablets With Codeine; Acetaminophen 500 Mg With 15 Mg Caffeine and 8 Mg Codeine Phosphate; Acetaminophen 500mg, Caffeine and 8mg Codeine Phosphate; Acetaminophen And Codeine; Acetaminophen And Codeine Phosphate; Acetaminophen Caffeine & 8mg Cod Phos Tab; Acetaminophen Caffeine & 8mg Cod. Phos. Tab; Acetaminophen Compound Tablets With Codeine 8mg; Acetaminophen Elixir With 8mg Codeine Phosphate Syrup; Acetaminophen W Codeine Tab; Acetaminophen With Codeine - Caplet; Acetaminophen and Codeine; Acetaminophen and Codeine Phosphate; Acetaminophen with Codeine; Acetaminophen, Aspirin and Codeine Phosphate; Acetaminophen, Caffeine & 8mg Codeine Phosphate; Acetaminophen, Caffeine & 8mg Codeine Phosphate Tablets; Acetaminophen, Caffeine & Codeine; Acetaminophen, Caffeine & Codeine Tablets; Acetaminophen, Caffeine and 8 Mg Of Codeine Phosphate Tablets; Acetaminophen, Caffeine and Codeine Phosphate Tablets; Acetaminophen, Caffeine, and 8mg Of Codeine Phosphate Tablets; Acetaminophen-caffeine-codeine; Acetaminophene Codeine Et Cafeine Caplets; Acetaminophene Codeine Et Cafeine Fort; Acetazone Forte C8; Acetylsalicylic Acid, Caffeine & 8 Mg Codeine Phosphate Tablets; Acetylsalicylic Acid, Caffeine and 8mg Codeine Phosphate; Airacof; Ala-hist Ac; Anacin With Codeine Tab; Apo-acetaco #1; Asa, Caffeine & 8mg Codeine Phosphate; Asa-caffeine-codeine; Ascomp with Codeine; Atasol 15; Atasol 30; Atasol 8; Axacet-C1/8; Axisal-C1/8; Balminil Codeine + Decongestant + Expectorant; Balminil Codeine Night Time + Expectorant; Benylin 2 Cold and Flu With Codeine; Benylin Codeine 3.3mg De Syr; Butalbital, Acetaminophen and Caffeine with Codeine Phosphate; Butalbital, Acetaminophen, Caffeine and Codeine Phosphate; Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate; Butalbital, Aspirin, Caffeine and Codeine Phosphate; Butalbital, Aspirin, Caffeine, and Codeine Phosphate; C T Acetylsalicylic Acid Codeine and Caf Tab; C-2 Buffered With Codeine; C2 Buffered With Codeine Tab; C2 Tab With Codeine; Calmylin; Calmylin Ace; Calmylin Codeine D-E Syr; Calmylin Pse With Codeine; CapCof; Capital and Codeine; Carisoprodol, Aspirin and Codeine Phosphate; Cheracol Cough Syrup; Cheratussin AC; Cheratussin DAC; Chlorpheniramine and Codeine; Coactifed; Cocet; Cocet Plus; Codar AR; Codar D; Codar GF; Codeine 15; Codeine 30; Codeine Contin 100mg Controlled Release Tab; Codeine Contin 150mg Controlled Release Tab; Codeine Contin 200mg Controlled Release Tab; Codeine Contin 50mg Controlled Release Tab; Codeine Phosphate Guaifenesin; Codeine Phosphate Inj 30mg/ml; Codeine Phosphate Inj 60mg/ml; Codeine Phosphate Injection USP; Codeine Phosphate Syrup; Codeine Phosphate Tab 15mg; Codeine Phosphate Tab 30mg; Codeine Phosphate Tab 60mg; Codeine Phosphate and Guaifenesin; Codeine Phosphate and Pseudoephedrine Hydrochloride; Codeine Sulfate; Codeine Tab 15mg; Codeine Tab 30mg; Codeine and Chlorpheniramine Maleate ER; Codeine sulfate; Codeine-Guaifenesin; Codeprex Pennkinetic; Coditussin AC; Coditussin DAC; Codrix; Coryphen 325 Codeine 30 Tab; Coryphen 650 Codeine 30 Tab; Cotabs; Cotrifed; Cough Syr W Codeine Diphenhyd HCl & Ammon Cl; Cough Syr W.cod. Pseudoephed.hcl Guaifenesin; Cough Syrup; Cough Syrup With Codeine; Cough and Allergy Syrup With Codeine; Covan Syrup; Damylin Avec Codeine Sirop; Damylin With Codeine Syrup; Dex-Tuss; Dexphen w/ Codeine; Dimetane Expectorant C; Dimetane Expectorant-C Syr; Dimetapp-C; Dimetapp-C Syr; Empracet-30; Empracet-60; EndaCof C; EndaCof DC; EndaCof-C; Endal CD; Exdol 15tab; Exdol 30tab; Exdol 8 Tab; Exdol-15; Exdol-30; Exdol-8; ExeClear C; Fioricet with Codeine; Fiorinal with Codeine; Fiorinal-C 1/2; Fiorinal-C 1/4; G Tussin AC; Ganituss Nr; Guaiatussin AC; Guaiatussin AC Sugar Free; Guaifenesin AC; Guaifenesin DAC; Guaifenesin and Codeine Phosphate; Guaifenesin and Codeine Phosphate SF; Histex Ac; Iophen C NR; Lexuss 210; Linctus Codeine Blanc; Lortuss EX; M-clear Wc; M-end Max D; M-end PE; M-end Wc; MAR-COF CG Expectorant; Mar-cof BP; Maxi-Tuss CD; Mersyndol With Codeine; Mesehist WC; Methoxacet-C 1/8; Methoxisal-C 1/2; Methoxisal-C 1/4; Methoxisal-C 1/8; Muscle & Back Pain Relief - 8; Muscle & Back Pain Relief-8; Muscle and Back Pain Relief - 8 Tablets; Muscle and Back Pain Relief Caplets; Muscle and Back Pain Relief-8; Nasotuss; Neo AC; Ninjacof-XG; Notuss PE; Notuss-NX; Notuss-NXD; Novahistex C; Novo Ac and C 8mg Tab; Novo-gesic C15; Novo-gesic C30; Novo-gesic-C8; Nu-acetaco #1; Oradrine Tablets; PHL-acet-codeine 30; PHL-acet-codeine 60; PMS-acetaminophen With Codeine Elixir; PMS-codeine; PMS-pharnal-C 1/4 Capsules; PMS-pharnal-C1/2 Capsules; Painex Tab 0.25gr; Painex Tab 0.5gr; Parafon Forte C8 W Codeine Tab; Paveral Liq 10mg/ml; Pentuss Srs; Phenaphen No 2 Cap; Phenaphen No 3 Cap; Phenaphen No 4 Cap; Phenaphen No.2 Cap; Phenaphen No.3 Cap; Phenaphen No.4 Cap; Phenylhistine DH; Phrenilin; Pluratuss; Poly Hist NC; Poly-Tussin AC; Poly-tussin; Poly-tussin D; Pracet 30; Pro-clear Ac; Pro-red Ac; Procet-30; Prometh with Codeine; Promethazine HCl and Codeine Phosphate; Promethazine HCl, Phenylephrine HCl and Codeine Phosphate; Promethazine HCl, Phenylephrine HCl, Codeine Phosphate; Promethazine Hydrochloride Phenylephrine Hydrochloride and Codeine Phosphate; Promethazine Hydrochloride and Codeine Phosphate; Promethazine Hydrochloride, Phenylephrine Hydrochloride and Codeine Phosphate; Promethazine VC With Codeine; Promethazine VC with Codeine; Promethazine Vc With Codeine; Promethazine Vc With Codine; Promethazine With Codeine; Promethazine with Codeine; Pronal - C1/2 Capsules; Pronal C1/4 Capsules; Pseudodine C; Ratio-codeine; RelCof-C; Robafen AC; Robaxacet-8; Robaxisal C 1/2; Robaxisal C 1/4; Robaxisal C-1/8 Tablets; Robitussin Ac; Robitussin Syrup With Codeine; Rounox Avec Codeine 15tab; Rounox Codeine 30 Tab; Rounox Codeine 60 Tab; Routec and Codeine 30 - Tab; Rydex; Sinutab With Codeine Tablets; Soma; Spasmhalt-8; Spasmhalt-asa-8; Stanley Syrup W Codeine Phosphate; Statuss Green; Suppress Cough Syr W.cod.diphen.hcl Amm.chl.; TYLENOL with Codeine; Tamicode Tablets; Terpin Hydrate Codeine Elx CF; Teva-codeine; Teva-cotridin; Teva-cotridin Expectorant; Teva-emtec-30; Teva-lenoltec No. 1; Teva-lenoltec No. 2; Teva-lenoltec No. 3; Teva-lenoltec No. 4; Teva-tecnal C 1/2; Teva-tecnal C 1/4; Theracodeine-300; Tl-hist CD; Tl-hist Cm; Triacin-C; Trianal C¼; Trianal C½; Triatec-30; Triatec-8; Triatec-8 Fort; Tricode AR; Tricode GF; Tusnel C; Tussaminic C Forte Syrup; Tussaminic C Pediatric Syrup; Tuxarin; Tuzistra XR; Tylenol No 1 Tab; Tylenol No.1 Caplets; Tylenol No.1 Forte Caplets; Tylenol No1 Forte Tablets With Codeine; Tylenol W Codeine No2 Tab; Tylenol W Codeine No3 Tab; Tylenol W Codeine No4 Tab; Tylenol With Codeine Elixir; Tylenol With Codeine No. 2 - Tab; Tylenol With Codeine No. 3 - Tab; Tylenol With Codeine No. 4; Virtussin A/C; Virtussin AC; Virtussin Ac W/alc; Virtussin DAC; Wampole-acetaminophen/codeine/caffeine; Z-tuss Ac; Z-tuss E; Zodryl AC 25; Zodryl AC 30; Zodryl AC 35; Zodryl AC 40; Zodryl AC 50; Zodryl AC 60; Zodryl AC 80; Zodryl DAC 25; Zodryl DAC 30; Zodryl DAC 35; Zodryl DAC 40; Zodryl DAC 50; Zodryl DAC 60; Zodryl DAC 80; Zodryl DEC 25; Zodryl DEC 30; Zodryl DEC 35; Zodryl DEC 40; Zodryl DEC 50; Zodryl DEC 60; Zodryl DEC 80; Zotex-C

> <INTERNATIONAL_BRANDS>
Actacode; Bisoltus; Bromophar; Bronchicum; Bronchodine; Codant; Codedrill; Codein; Codeisan; Coderpina; Codicalm; Codicept; Codinex; Coducept; Cougel; Coutan; Dinco; Farmacod; Galcodine; Pectoral; Tussoret

> <SALTS>
Codeine hydrochloride; Codeine monohydrate; Codeine phosphate; Codeine phosphate hemihydrate; Codeine sulfate; Codeine sulfate anhydrous

$$$$
327
  Mrv0541 02231214362D          

 24 28  0  0  1  0            999 V2000
    1.9356   -0.2231    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7349   -2.3527    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7349    1.8149    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3440   -1.0939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2006   -0.6814    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.9151   -1.0939    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.6296   -0.6814    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.4861   -1.0939    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.6773   -0.0764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2006    0.1436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9151   -1.9190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6296    0.1436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8506   -0.0764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9151    0.5561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2006   -2.3315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4861   -1.9190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4861    0.5561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9350   -1.7290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9151    1.3811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4861    1.3811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2006    1.7936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3612   -1.6255    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    4.8675   -1.3334    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.8196   -1.2870    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  8  1  0  0  0  0
  1 17  1  0  0  0  0
  2 16  2  0  0  0  0
  3 20  1  0  0  0  0
  4  7  1  0  0  0  0
  4 13  1  0  0  0  0
  4 18  1  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  5  9  1  1  0  0  0
  5 10  1  0  0  0  0
  6  7  1  0  0  0  0
  6 11  1  0  0  0  0
  6 22  1  1  0  0  0
  7 12  1  0  0  0  0
  7 23  1  6  0  0  0
  8 16  1  0  0  0  0
  8 24  1  1  0  0  0
  9 13  1  0  0  0  0
 10 14  2  0  0  0  0
 10 17  1  0  0  0  0
 11 15  1  0  0  0  0
 12 14  1  0  0  0  0
 14 19  1  0  0  0  0
 15 16  1  0  0  0  0
 17 20  2  0  0  0  0
 19 21  2  0  0  0  0
 20 21  1  0  0  0  0
M  END
> <DATABASE_ID>
DB00327

> <DATABASE_NAME>
drugbank

> <SMILES>
[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O

> <INCHI_IDENTIFIER>
InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1

> <INCHI_KEY>
WVLOADHCBXTIJK-YNHQPCIGSA-N

> <FORMULA>
C17H19NO3

> <MOLECULAR_WEIGHT>
285.3377

> <EXACT_MASS>
285.136493479

> <JCHEM_ACCEPTOR_COUNT>
4

> <JCHEM_AVERAGE_POLARIZABILITY>
30.023248428425724

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
1

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
1

> <JCHEM_IUPAC>
(1S,5R,13R,17R)-10-hydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-trien-14-one

> <ALOGPS_LOGP>
1.69

> <JCHEM_LOGP>
1.6227496759764108

> <ALOGPS_LOGS>
-1.81

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
5

> <JCHEM_PHYSIOLOGICAL_CHARGE>
1

> <JCHEM_PKA>
18.00207891919619

> <JCHEM_PKA_STRONGEST_ACIDIC>
10.107628114711872

> <JCHEM_PKA_STRONGEST_BASIC>
8.586674910405563

> <JCHEM_POLAR_SURFACE_AREA>
49.77

> <JCHEM_REFRACTIVITY>
78.26240000000001

> <JCHEM_ROTATABLE_BOND_COUNT>
0

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
4.39e+00 g/l

> <JCHEM_TRADITIONAL_IUPAC>
hydromorphone

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB00327

> <SECONDARY_ACCESSION_NUMBERS>
APRD01021

> <DRUG_GROUPS>
approved; illicit

> <GENERIC_NAME>
Hydromorphone

> <SYNONYMS>
(-)-(5R)-4,5-Epoxy-3-hydroxy-9α-methylmorphinan-6-one; 4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one; 4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone; 6-Deoxy-7,8-dihydro-6-oxomorphine; 7,8-Dihydromorphinone; Dihydromorfinon; Dihydromorphinone; Dimorphone; Hidromorfona; Hydromorfona; Hydromorphone; Hydromorphonum; Idromorfone

> <PRODUCTS>
Apo-hydromorphone; Apo-hydromorphone CR; Bar-hydromorphone CR; Dilaudid; Dilaudid Hp; Dilaudid-HP; Dilaudid-HP-plus; Dilaudid-XP; Exalgo; HYDROmorphone Hydrochloride; Hydromorph Contin; Hydromorph Contin-controlled Release Cap - 12mg; Hydromorph Contin-controlled Release Cap - 18mg; Hydromorph Contin-controlled Release Cap - 24mg; Hydromorph Contin-controlled Release Cap - 30mg; Hydromorph Contin-controlled Release Cap - 3mg; Hydromorph Contin-controlled Release Cap - 6mg; Hydromorph.ir - 2mg; Hydromorph.ir - 4mg; Hydromorph.ir - 8mg; Hydromorphone; Hydromorphone HCl; Hydromorphone HCl Tab 2mg USP; Hydromorphone HCl Tab 4mg USP; Hydromorphone Hp 10; Hydromorphone Hp 20; Hydromorphone Hp 50; Hydromorphone Hp Forte Injection; Hydromorphone Hydrochloride; Hydromorphone Hydrochloride Extended-Release; Hydromorphone Hydrochloride Injection; Hydromorphone Hydrochloride Injection Hp 10; Hydromorphone Hydrochloride Injection Hp 50; Hydromorphone Hydrochloride Injection Hp Forte; Hydromorphone Hydrochloride Injection USP; Hydromorphone Hydrochloride Injection, USP; Hydromorphone Hydrochloride Sup 3mg; Hydromorphone hydrochloride; Hyrdomorphone Hydrochloride; Jurnista; PHL-hydromorphone; PHL-hydromorphone -syr 1mg/ml; PMS Hydromorphone Sirop 1mg/ml; PMS Hydromorphone Suppositoire 3mg; PMS-hydromorphone Tab 1mg; PMS-hydromorphone Tab 2mg; PMS-hydromorphone Tab 4mg; PMS-hydromorphone Tab 8mg; Palladone; Palladone XL - 12mg; Palladone XL - 16mg; Palladone XL - 24mg; Teva-hydromorphone

> <SALTS>
Hydromorphone hydrochloride; Hydromorphone sulfate

$$$$
349
  Mrv0541 02231214372D          

 21 23  0  0  0  0            999 V2000
    2.8172   -2.3593    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.1124    1.1545    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6107    2.3593    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1245    0.1666    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4543    0.9709    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3812   -0.1914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6379    0.1666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7937    1.6159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3081    0.9709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9687    1.6159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7695   -0.3478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4586   -1.0473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9205   -0.3065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500    1.1545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7524   -1.5367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9781   -1.1639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5375   -0.0464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6466   -1.1636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1825   -0.5608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2915   -1.6780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0595   -1.3765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 15  1  0  0  0  0
  2  9  2  0  0  0  0
  3 10  2  0  0  0  0
  4  6  1  0  0  0  0
  4  9  1  0  0  0  0
  4 11  1  0  0  0  0
  5  7  1  0  0  0  0
  5 10  1  0  0  0  0
  5 14  1  0  0  0  0
  6  7  2  0  0  0  0
  6 12  1  0  0  0  0
  7 13  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 11 17  2  0  0  0  0
 11 18  1  0  0  0  0
 12 15  2  0  0  0  0
 13 16  2  0  0  0  0
 15 16  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  2  0  0  0  0
 19 21  2  0  0  0  0
 20 21  1  0  0  0  0
M  END
> <DATABASE_ID>
DB00349

> <DATABASE_NAME>
drugbank

> <SMILES>
CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O

> <INCHI_IDENTIFIER>
InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3

> <INCHI_KEY>
CXOXHMZGEKVPMT-UHFFFAOYSA-N

> <FORMULA>
C16H13ClN2O2

> <MOLECULAR_WEIGHT>
300.74

> <EXACT_MASS>
300.066555377

> <JCHEM_ACCEPTOR_COUNT>
2

> <JCHEM_AVERAGE_POLARIZABILITY>
30.066074049985147

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
0

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
1

> <JCHEM_IUPAC>
7-chloro-1-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-2,4-dione

> <ALOGPS_LOGP>
2.14

> <JCHEM_LOGP>
2.554375973333333

> <ALOGPS_LOGS>
-3.26

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
3

> <JCHEM_PHYSIOLOGICAL_CHARGE>
-1

> <JCHEM_PKA_STRONGEST_ACIDIC>
4.068303914570974

> <JCHEM_PKA_STRONGEST_BASIC>
-6.723067238972568

> <JCHEM_POLAR_SURFACE_AREA>
40.620000000000005

> <JCHEM_REFRACTIVITY>
80.29860000000004

> <JCHEM_ROTATABLE_BOND_COUNT>
1

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
1.64e-01 g/l

> <JCHEM_TRADITIONAL_IUPAC>
clobazam

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB00349

> <SECONDARY_ACCESSION_NUMBERS>
APRD00307

> <DRUG_GROUPS>
approved; illicit

> <GENERIC_NAME>
Clobazam

> <SYNONYMS>
1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine; 7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione; Clobazam; Clobazamum

> <PRODUCTS>
Apo-clobazam; Clobazam; Clobazam-10; Dom-clobazam; Frisium Tab 10mg; Frisium Tablet 10mg; Frisium Tablets 10mg; Ntp-clobazam; Onfi; PMS-clobazam; Ratio-clobazam; Sympazan; Teva-clobazam

> <INTERNATIONAL_BRANDS>
Aedon; Castilium; Clobam; Clobamax; Frisium; Grifoclobam; Mystan; Noiafren; Sederlona; Urbanil; Urbanol; Urbanyl; Venium

$$$$
371
  Mrv0541 02231214382D          

 15 14  0  0  0  0            999 V2000
    6.3799   -0.4529    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220   -0.4529    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0944    0.7846    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -1.6905    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8089   -0.4529    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930   -0.4529    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509   -0.4529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5384    0.2615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6655   -0.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365   -0.8654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3634   -1.1675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509    0.9760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5384    1.6905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0944   -0.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -0.8654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0  0  0  0
  1 14  1  0  0  0  0
  2 10  1  0  0  0  0
  2 15  1  0  0  0  0
  3 14  2  0  0  0  0
  4 15  2  0  0  0  0
  5 14  1  0  0  0  0
  6 15  1  0  0  0  0
  7  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8 12  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
> <DATABASE_ID>
DB00371

> <DATABASE_NAME>
drugbank

> <SMILES>
CCCC(C)(COC(N)=O)COC(N)=O

> <INCHI_IDENTIFIER>
InChI=1S/C9H18N2O4/c1-3-4-9(2,5-14-7(10)12)6-15-8(11)13/h3-6H2,1-2H3,(H2,10,12)(H2,11,13)

> <INCHI_KEY>
NPPQSCRMBWNHMW-UHFFFAOYSA-N

> <FORMULA>
C9H18N2O4

> <MOLECULAR_WEIGHT>
218.2502

> <EXACT_MASS>
218.126657074

> <JCHEM_ACCEPTOR_COUNT>
2

> <JCHEM_AVERAGE_POLARIZABILITY>
22.653083876522018

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
1

> <JCHEM_IUPAC>
2-[(carbamoyloxy)methyl]-2-methylpentyl carbamate

> <ALOGPS_LOGP>
1.06

> <JCHEM_LOGP>
0.9272528839999998

> <ALOGPS_LOGS>
-1.95

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
0

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_PKA>
15.63114431855761

> <JCHEM_PKA_STRONGEST_ACIDIC>
15.171696837219113

> <JCHEM_POLAR_SURFACE_AREA>
104.64

> <JCHEM_REFRACTIVITY>
53.03669999999999

> <JCHEM_ROTATABLE_BOND_COUNT>
8

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
2.47e+00 g/l

> <JCHEM_TRADITIONAL_IUPAC>
sowell

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB00371

> <SECONDARY_ACCESSION_NUMBERS>
APRD01095

> <DRUG_GROUPS>
approved; illicit

> <GENERIC_NAME>
Meprobamate

> <SYNONYMS>
Meprobamat; Meprobamate; Meprobamato; Meprobamatum; Meprobamic acid

> <PRODUCTS>
282 Mep Tab; Apo Meprobamate Tab 400mg; Equagesic; Equagesic Tablets; Equanil Tablets 400mg; Meditran 400mg; Meprobamate; Meprobamate Tab 400mg; Novo-mepro 200mg; Novo-mepro 400mg

> <INTERNATIONAL_BRANDS>
Equanil; Meprospan; Miltown

$$$$
404
  Mrv0541 02231214392D          

 22 25  0  0  0  0            999 V2000
    1.6500   -0.2321    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.8159   -1.3269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2284    0.4805    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1244   -1.5631    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7352   -2.2849    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0726   -0.9689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8890   -0.1645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5592   -0.9689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4034    0.4805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7428   -0.1645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9281   -2.1392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4517   -1.5630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0718    0.1014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0454    1.2238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6286   -1.3160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4374   -0.4783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3328   -2.7104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2227    1.2854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5102    1.9054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8648    2.0288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1523    2.6488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3296    2.7104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 16  1  0  0  0  0
  2  6  1  0  0  0  0
  2  8  1  0  0  0  0
  2 11  1  0  0  0  0
  3  9  2  0  0  0  0
  3 10  1  0  0  0  0
  4  5  1  0  0  0  0
  4  8  2  0  0  0  0
  5 11  2  0  0  0  0
  6  7  2  0  0  0  0
  6 12  1  0  0  0  0
  7  9  1  0  0  0  0
  7 13  1  0  0  0  0
  8 10  1  0  0  0  0
  9 14  1  0  0  0  0
 11 17  1  0  0  0  0
 12 15  2  0  0  0  0
 13 16  2  0  0  0  0
 14 18  2  0  0  0  0
 14 19  1  0  0  0  0
 15 16  1  0  0  0  0
 18 20  1  0  0  0  0
 19 21  2  0  0  0  0
 20 22  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
> <DATABASE_ID>
DB00404

> <DATABASE_NAME>
drugbank

> <SMILES>
CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12

> <INCHI_IDENTIFIER>
InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3

> <INCHI_KEY>
VREFGVBLTWBCJP-UHFFFAOYSA-N

> <FORMULA>
C17H13ClN4

> <MOLECULAR_WEIGHT>
308.765

> <EXACT_MASS>
308.082874143

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_AVERAGE_POLARIZABILITY>
32.21940045856445

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
0

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
1

> <JCHEM_IUPAC>
12-chloro-3-methyl-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaene

> <ALOGPS_LOGP>
2.23

> <JCHEM_LOGP>
2.3741000000000003

> <ALOGPS_LOGS>
-3.98

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
4

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_PKA_STRONGEST_ACIDIC>
18.2996362847328

> <JCHEM_PKA_STRONGEST_BASIC>
5.076680256062132

> <JCHEM_POLAR_SURFACE_AREA>
43.07

> <JCHEM_REFRACTIVITY>
98.87900000000002

> <JCHEM_ROTATABLE_BOND_COUNT>
1

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
3.24e-02 g/l

> <JCHEM_TRADITIONAL_IUPAC>
neurol

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB00404

> <SECONDARY_ACCESSION_NUMBERS>
APRD00280; DB05925; DB05690

> <DRUG_GROUPS>
approved; illicit; investigational

> <GENERIC_NAME>
Alprazolam

> <SYNONYMS>
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine; Alprazolam

> <PRODUCTS>
ALPRAZOLAM extended release; Alprazolam; Alprazolam ER; Alprazolam Extended Release; Alprazolam Extended-Release; Alprazolam Extended-release; Alprazolam Tablets 0.25; Alprazolam Tablets 0.5mg; Alprazolam Ts; Alprazolam XR; Alprazolam-0.25; Alprazolam-0.5; Apo-alpraz; Apo-alpraz Ts; Gabazolamine; Gabazolamine-0.5; Ipg-alprazolam; Jamp-alprazolam; Mylan-alprazolam; Nat-alprazolam; Niravam; Ntp-alprazolam; Nu-alpraz Tab 0.25mg; Nu-alpraz Tab 0.5mg; Ratio-alprazolam; Riva-alprazolam; Riva-alprazolam 0.25 mg; Riva-alprazolam 0.5 mg; Sentrazolam AM; Teva-alprazolam; Xanax; Xanax Tab 0.5mg; Xanax Tab 1mg; Xanax Ts; Xanax XR

> <INTERNATIONAL_BRANDS>
Alplax; Alprazolan; Alpronax; Alprox; Alviz; Cassadan; Esparon; Ralozam; Restyl; Solanax; Staccato alprazolam; Tafil; Trankimazin; Tranquinal; Xanor

$$$$

  Mrv0541 09031308382D          

 25 27  0  0  1  0            999 V2000
    7.6955   -5.8135    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.4043   -6.2242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9797   -6.2242    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.6989   -4.9925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4043   -7.0523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1200   -5.8135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9797   -7.0523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2674   -5.8101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9833   -4.5786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6955   -7.4627    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1200   -7.4627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8289   -6.2242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1200   -4.9891    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2674   -4.9891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9867   -3.7575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8289   -7.0523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5411   -7.4627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2569   -7.0487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9656   -7.4593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6814   -7.0487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3901   -7.4593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3657   -5.3925    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    6.1587   -6.7681    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    6.9797   -7.8773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2652   -7.4648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  6 13  1  0  0  0  0
  8 14  1  0  0  0  0
  9 15  1  0  0  0  0
 11 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
  7 10  1  0  0  0  0
  9 14  1  0  0  0  0
 12 16  1  0  0  0  0
  1 22  1  6  0  0  0
  3 23  1  1  0  0  0
  7 24  1  0  0  0  0
  7 25  1  0  0  0  0
M  END
> <DATABASE_ID>
DB00470

> <DATABASE_NAME>
drugbank

> <SMILES>
[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1

> <INCHI_IDENTIFIER>
InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1

> <INCHI_KEY>
CYQFCXCEBYINGO-IAGOWNOFSA-N

> <FORMULA>
C21H30O2

> <MOLECULAR_WEIGHT>
314.4617

> <EXACT_MASS>
314.224580204

> <JCHEM_ACCEPTOR_COUNT>
2

> <JCHEM_AVERAGE_POLARIZABILITY>
38.956941218234675

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
1

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
0

> <JCHEM_IUPAC>
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6H,6aH,7H,8H,10aH-benzo[c]isochromen-1-ol

> <ALOGPS_LOGP>
7.29

> <JCHEM_LOGP>
5.944157107333333

> <ALOGPS_LOGS>
-5.08

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
3

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_PKA_STRONGEST_ACIDIC>
9.342429150192967

> <JCHEM_PKA_STRONGEST_BASIC>
-4.893304388168227

> <JCHEM_POLAR_SURFACE_AREA>
29.46

> <JCHEM_REFRACTIVITY>
96.73350000000002

> <JCHEM_ROTATABLE_BOND_COUNT>
4

> <JCHEM_RULE_OF_FIVE>
0

> <ALOGPS_SOLUBILITY>
2.63e-03 g/l

> <JCHEM_TRADITIONAL_IUPAC>
THC

> <JCHEM_VEBER_RULE>
1

> <DRUGBANK_ID>
DB00470

> <SECONDARY_ACCESSION_NUMBERS>
APRD00571

> <DRUG_GROUPS>
approved; illicit

> <GENERIC_NAME>
Dronabinol

> <SYNONYMS>
(-)-delta9-trans-Tetrahydrocannabinol; 1-trans-delta-9-Tetrahydrocannabinol; 3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol; 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol; delta-9-tetrahydrocannabinol; delta-9-THC; delta(1)-tetrahydrocannabinol; delta(9)-THC; delta9-tetrahydrocannabinol; Dronabinol; Dronabinolum; Tetrahydrocannabinol; THC; Δ9-tetrahydrocannabinol

> <PRODUCTS>
Dronabinol; Marinol; Marinol Cap 10mg; Sativex; Syndros

$$$$

  Mrv1718010311718302D          

 21 23  0  0  0  0            999 V2000
    1.5326   -0.3143    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0
    0.0998    0.0219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7431   -0.4897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7431    1.3669    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8982    0.4312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0998    0.8553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5326    1.1916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0493   -0.9576    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
   -0.6165   -0.3874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3095   -1.1916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6165    1.2646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0493    1.8641    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3329    0.0073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3329    0.8698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0493   -0.4312    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.5238   -1.1769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7042   -1.9080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7276    2.6244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9527   -1.8933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2753   -2.6244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5433   -2.6244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0  0  0  0
  3  1  2  0  0  0  0
  4  7  2  0  0  0  0
  5  1  1  0  0  0  0
  6  2  2  0  0  0  0
  7  5  1  0  0  0  0
  8  1  1  0  0  0  0
  9  2  1  0  0  0  0
 10  3  1  0  0  0  0
 11  6  1  0  0  0  0
 12  7  1  0  0  0  0
 13  9  2  0  0  0  0
 14 13  1  0  0  0  0
 15 13  1  0  0  0  0
 16 10  1  0  0  0  0
 17 10  2  0  0  0  0
 18 12  1  0  0  0  0
 19 16  2  0  0  0  0
 20 17  1  0  0  0  0
 21 19  1  0  0  0  0
  6  4  1  0  0  0  0
 20 21  2  0  0  0  0
 11 14  2  0  0  0  0
M  CHG  2   1   1   8  -1
M  END
> <DATABASE_ID>
DB00475

> <DATABASE_NAME>
drugbank

> <SMILES>
CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1

> <INCHI_IDENTIFIER>
InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9H,10H2,1H3,(H,18,19)

> <INCHI_KEY>
ANTSCNMPPGJYLG-UHFFFAOYSA-N

> <FORMULA>
C16H14ClN3O

> <MOLECULAR_WEIGHT>
299.755

> <EXACT_MASS>
299.082539792

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_ATOM_COUNT>
35

> <JCHEM_AVERAGE_POLARIZABILITY>
31.220681309216832

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
1

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
1

> <JCHEM_IUPAC>
7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepin-4-ium-4-olate

> <ALOGPS_LOGP>
2.01

> <JCHEM_LOGP>
0.18956609050315829

> <ALOGPS_LOGS>
-4.18

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
3

> <JCHEM_PHYSIOLOGICAL_CHARGE>
1

> <JCHEM_PKA>
16.431798916705144

> <JCHEM_PKA_STRONGEST_ACIDIC>
-2.687983529116578

> <JCHEM_PKA_STRONGEST_BASIC>
7.061261704810951

> <JCHEM_POLAR_SURFACE_AREA>
50.46

> <JCHEM_REFRACTIVITY>
87.3403

> <JCHEM_ROTATABLE_BOND_COUNT>
1

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
1.99e-02 g/l

> <JCHEM_TRADITIONAL_IUPAC>
chlordiazepoxide

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB00475

> <SECONDARY_ACCESSION_NUMBERS>
APRD00682

> <DRUG_GROUPS>
approved; illicit; investigational

> <GENERIC_NAME>
Chlordiazepoxide

> <SYNONYMS>
7-chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide; CDP; Chloradiazepoxide; Chlordiazepoxide; Chlordiazepoxidum; Clopoxide; Clordiazepóxido; Methaminodiazepoxide

> <PRODUCTS>
CHLORDIAZEPOXIDE HYDROCHLORIDE and CLIDINIUM BROMIDE; Chlorax; Chlordiazepoxide; Chlordiazepoxide Cap 10mg; Chlordiazepoxide Cap 5mg; Chlordiazepoxide Clidinium; Chlordiazepoxide HCl; Chlordiazepoxide Hydrochloride; Chlordiazepoxide Hydrochloride And Clidinium Bromide; Chlordiazepoxide Hydrochloride and Clidinium Bromide; Chlordiazepoxide Hydrochloride/Clidinium Bromide; Chlordiazepoxide and Amitriptyline HCl; Chlordiazepoxide and Amitriptyline Hydrochloride; Chlordiazepoxyde 25 Cap; Chlordiazepoxyde Cap 10mg; Chlordiazepoxyde HCl Cap 25mg; Corax Cap 10mg; Corax Cap 25mg; Corax Cap 5mg; Corium Cap; Librax; Librium; Limbitrol; Limbitrol DS; Medilium Cap 10 10mg; Medilium Cap 5mg; Novo-poxide 10mg; Novo-poxide 25mg; Novo-poxide 5mg; Nu-chlorax Capsules USP; Pro Chlorax

> <INTERNATIONAL_BRANDS>
Angirex; Elenium; Helogaphen; Klopoxid; Libritabs; Multum; Napoton; Radepur; Risolid; Silibrin; Sonimen; Tropium

> <SALTS>
Chlordiazepoxide hydrochloride

$$$$